Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$15.6M Buy
151,950
+7,663
+5% +$826K 0.63% 21
2023
Q2
$16.6M Buy
144,287
+22,718
+19% +$2.58M 0.78% 17
2023
Q1
$12.9M Buy
121,569
+12,726
+12% +$1.37M 0.71% 21
2022
Q4
$12.1M Buy
108,843
+10,459
+11% +$1.07M 0.75% 21
2022
Q3
$8.47M Buy
+98,384
New +$8.78M 0.64% 25

Other funds holding MRK

Advisor Partners II's MRK Position: Q3 2023 in Review

Advisor Partners II increased its Merck (MRK) stake by 5.3% in Q3 2023, buying an estimated $826K and bringing the position to 151,950 shares worth $15.6M. The position accounts for 0.63% of the portfolio, ranked #21.

Advisor Partners II first reported a position in MRK in Q3 2022 and has held it in 5 quarters since. The position peaked at $16.6M in Q2 2023. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Advisor Partners II held 151,950 shares of Merck worth $15.6M as of Q3 2023.
  • Advisor Partners II bought 7,663 Merck shares in Q3 2023, an estimated $826K.
  • Merck made up 0.63% of Advisor Partners II's portfolio in Q3 2023, its #21 holding.
  • Advisor Partners II first reported a position in Merck in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Merck position peaked at $16.6M in Q2 2023.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.